Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Assisted Reproduction and Genetics

• Publication date

  2016-04-06

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1007/s10815-016-0710-8PMID 27052831PMCID PMC4870449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells

  2015cited by this paper
• Small molecules enhance CRISPR genome editing in pluripotent stem cells.

  2015cited by this paper
• CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes

  2015influential reference
• A prudent path forward for genomic engineering and germline gene modification

  2015cited by this paper
• Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

  2015cited by this paper
• Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases

  2014cited by this paper
• Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model.

  2014cited by this paper
• Development and Applications of CRISPR-Cas 9 for Genome Engineering

  2014cited by this paper
• Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.

  2014cited by this paper
• Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing

  2014cited by this paper
• Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

  2014cited by this paper
• Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.

  2014cited by this paper
• Development and applications of CRISPR-Cas9 for genome engineering.

  2014cited by this paper
• Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells

  2014cited by this paper
• GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

  2014cited by this paper
• Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

  2014cited by this paper
• TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys.

  2014cited by this paper
• Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection

  2014cited by this paper
• Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNA

  2014cited by this paper
• One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

  2013cited by this paper
• Multiplex Genome Engineering Using CRISPR/Cas Systems

  2013cited by this paper
• Correction of a genetic disease in mouse via use of CRISPR-Cas9.

  2013cited by this paper
• Low Immunogenicity of Neural Progenitor Cells Differentiated from Induced Pluripotent Stem Cells Derived from Less Immunogenic Somatic Cells

  2013cited by this paper
• Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

  2013cited by this paper
• DNA targeting specificity of RNA-guided Cas9 nucleases

  2013cited by this paper
• Generation and Genetic Engineering of Human Induced Pluripotent Stem Cells Using Designed Zinc Finger Nucleases

  2013cited by this paper
• One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering.

  2013cited by this paper
• Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases

  2013cited by this paper
• Generation of CD34+ Cells from CCR5-Disrupted Human Embryonic and Induced Pluripotent Stem Cells

  2012cited by this paper
• TAL Effectors: Customizable Proteins for DNA Targeting

  2011cited by this paper
• Knockout rats generated by embryo microinjection of TALENs

  2011cited by this paper
• Genome editing with engineered zinc finger nucleases

  2010cited by this paper
• Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

  2010cited by this paper
• Can ‘abnormally’ fertilized zygotes give rise to viable embryos?

  2006cited by this paper
• The sequence of the human genome (abstract only)

  2001cited by this paper
• Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.

  2001cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Homozygous and Heterozygous CCR5‐&Dgr;32 Genotypes Are Associated With Resistance to HIV Infection

  2001cited by this paper
• Global distribution of the CCR5 gene 32-basepair deletion

  1997cited by this paper
• Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

  1996cited by this paper
• Fertilization and early embryology: Tripronuclear human zygotes: the first cell cycle and subsequent development

  1993cited by this paper
• Tripronuclear human oocytes: altered cleavage patterns and subsequent karyotypic analysis of embryos.

  1987cited by this paper
• Sequence the Human Genome

  1986cited by this paper

• The Application of CRISPR-Based Genetic Engineering for the Elimination of Harmful Inherited Diseases in Human Embryos

  2026influential citation
• The Case for Germline Gene Correction: State of the Science.

  2025cites this paper
• Familiarity Matters: Examining the Effects of AI-Generated Images on Science Information Credibility

  2025cites this paper
• Human health and genetic technology.

  2025cites this paper
• CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment

  2025cites this paper
• Improving the Efficiency and Safety of Human CCR5 Gene Editing by Selection of Optimal Guide RNAs for SpCAS9 and CAS12A

  2025cites this paper
• Application and Prospect of Gene Editing Technology in Immunotherapy

  2025cites this paper
• Emerging Medical Technologies and Their Use in Bionic Repair and Human Augmentation

  2024cites this paper
• Developmental progression of DNA double-strand break repair deciphered by a single-allele resolution mutation classifier

  2024cites this paper
• Genome editing and its role in vaccine, diagnosis, and therapeutic advancement.

  2024cites this paper
• Governing with public engagement: an anticipatory approach to human genome editing

  2024cites this paper
• CRISPR/Cas9 technology: applications in oocytes and early embryos

  2023cites this paper
• Seven open questions in the futures of human genome editing.

  2023cites this paper
• Should we use CRISPR gene editing in human embryos?

  2023cites this paper
• Base editors: development and applications in biomedicine

  2023cites this paper
• Researching the future: scenarios to explore the future of human genome editing

  2023cites this paper
• AN INCREASE IN THE INFECTIVITY OF THE HUMAN IMMUNODEFICIENCY VIRUS WITH MODIFICATION OF THE CCR5 GENE RECEPTOR OF SENSITIVE CELLS

  2023cites this paper
• Using molecular dynamics simulations to show differences of movement over time in the CCR5 variants of genetically edited children

  2023cites this paper
• Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research

  2023cites this paper
• The History, Use, and Challenges of Therapeutic Somatic Cell and Germline Gene Editing.

  2023cites this paper
• Exosomes for CRISPR-Cas9 Delivery: The Cutting Edge in Genome Editing

  2023cites this paper
• Is the world ready for human germline genetic editing using CRISPR/Cas9?

  2023cites this paper
• Higher Infectivity of the Human Immunodeficiency Virus in Sensitive Cells with a Modification of the CCR5 Gene

  2023cites this paper
• Ethical Perspectives of Therapeutic Human Genome Editing From Multiple and Diverse Viewpoints: A Scoping Review

  2022cites this paper
• Nanoparticle‐mediated genome editing in single‐cell embryos via peptide nucleic acids

  2022cites this paper
• Administration and Detection of Gene Therapy in Horses: a systematic review.

  2022cites this paper
• CRISPR/Cas gene editing in the human germline.

  2022cites this paper
• Detection of CCR5Δ32 Mutant Alleles in Heterogeneous Cell Mixtures Using Droplet Digital PCR

  2022cites this paper
• Gene Editing Through CRISPR-Based Technology

  2022cites this paper
• A short, idiosyncratic history of genome editing

  2021cites this paper
• Human embryonic genome activation initiates at the one-cell stage

  2021cites this paper
• Bi-functionalized aminoguanidine-PEGylated periodic mesoporous organosilica nanoparticles: a promising nanocarrier for delivery of Cas9-sgRNA ribonucleoproteine

  2021cites this paper
• Excluding embryos with two novel mutations in FREM2 gene by the next-generation sequencing-based single nucleotide polymorphism haplotyping

  2021cites this paper
• AttCRISPR: a spacetime interpretable model for prediction of sgRNA on-target activity

  2021cites this paper
• The platforming of human embryo editing: prospecting “disease free” futures

  2021cites this paper
• The Inclusion Principles of Human Embryos in the WOW-Based Time-Lapse System: A Retrospective Cohort Study

  2021cites this paper
• Human Germline Genome Editing: On the Nature of Our Reasons to Genome Edit

  2021cites this paper
• Toward Anticipatory Governance of Human Genome Editing: A Critical Review of Scholarly Governance Discourse.

  2021cites this paper
• CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues

  2021cites this paper
• Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19.

  2021cites this paper
• Making sense of heritable human genome editing: Scientific and ethical considerations.

  2021cites this paper
• Application of CRISPR‐Cas9 Technology in Bovine Reproduction

  2021cites this paper
• Characterization of Substitution Mutations of eIF4G Gene Generated through Adenine Base Editors in Rice

  2021cites this paper
• Editing Properties of Base Editors with SpCas9-NG in Discarded Human Tripronuclear Zygotes

  2021cites this paper
• You can't keep a bad idea down: Dark history, death, and potential rebirth of eugenics

  2021cites this paper
• Regulating genetic engineering guided by human dignity, not genetic essentialism

  2021cites this paper
• Global Governance of Human Genome Editing: What Are the Rules?

  2021cites this paper
• Heritable human genome editing: Research progress, ethical considerations, and hurdles to clinical practice.

  2021cites this paper
• Human embryo gene editing: God's scalpel or Pandora's box?

  2020cites this paper
• Ethics in embryo research: a position statement by the ASRM Ethics in Embryo Research Task Force and the ASRM Ethics Committee.

  2020cites this paper
• Developmental insights and biomedical potential of human embryonic stem cells : modelling trophoblast differentiation and establishing novel cell therapies for age-related macular degeneration

  2020cites this paper
• CRISPR Gene Editing on Human Embryos

  2020cites this paper
• Reproductive medicine involving genome editing

  2020cites this paper
• Neuroenhancement and Law

  2020cites this paper
• Advances in genome editing technology and its applications in poultry breeding

  2020cites this paper
• IMPLICACIONES ÉTICO-JURÍDICAS DE LA EDICIÓN DE GENES

  2020cites this paper
• Various Aspects of a Gene Editing System—CRISPR–Cas9

  2020cites this paper
• Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy

  2020cites this paper
• Rewriting the Future: Promises and Limits of Germline Gene Editing in Craniofacial Surgery.

  2020cites this paper
• The Regulation of Human Germline Genome Modification in the People’s Republic of China

  2020cites this paper
• The Regulation of Human Germline Genome Modification in Australia

  2020cites this paper
• CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss

  2020cites this paper
• Use of Customizable Nucleases for Gene Editing and Other Novel Applications

  2020cites this paper
• Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos

  2020cites this paper
• Genetics experience impacts attitudes towards germline gene editing: a survey of over 1500 members of the public

  2020cites this paper
• Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy.

  2020cites this paper
• Genome editing, or CRISPR/CAS9 — a panacea for many incurable diseases or the first step to a gene apocalypse?

  2020cites this paper
• Prediction of piRNAs and their function based on discriminative intelligent model using hybrid features into Chou’s PseKNC

  2020cites this paper
• Enabling large-scale genome editing at repetitive elements by reducing DNA nicking

  2020cites this paper
• Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia

  2020cites this paper
• Heritable genome editing: looking through the crystal ball

  2020cites this paper
• CRISPR-Cas9 Technology, Safety and Evaluation from an Ethical Perspective

  2020cites this paper
• Ethical issues related to research on genome editing in human embryos

  2020cites this paper
• Emergent challenges for CRISPR: biosafety, biosecurity, patenting, and regulatory issues

  2020cites this paper
• Lysosomal storage diseases: current therapies and future alternatives

  2020cites this paper
• Recent advances in mammalian reproductive biology

  2019cites this paper
• Preimplantation genome editing: CCR5 in China.

  2019cites this paper
• The technical risks of human gene editing.

  2019cites this paper
• Safety of Germline Genome Editing for Genetically Related “Future” Children as Perceived by Parents

  2019cites this paper
• Designing Preclinical Studies in Germline Gene Editing: Scientific and Ethical Aspects

  2019cites this paper
• Edição genética: riscos e benefícios da modificação do DNA humano

  2019cites this paper
• Patent Governance, Ethics and Democracy: How Transparency and Accountability Norms Are Challenged by Patents on Stem Cells, Gametes and Genome Editing (CRISPR) in Europe

  2019cites this paper
• Estimating Demand for Germline Genome Editing: An In Vitro Fertilization Clinic Perspective

  2019cites this paper
• CRISPR-CAS9. El mayor avance en técnicas de edición genética requiere una reflexión ética

  2019cites this paper
• Application of Gene-Editing Technologies in Embryos and Their Potential for Gene Therapy

  2019cites this paper
• Legal framework for gene editing in human genome “ World ’ s First Mutant twins by China ”

  2019cites this paper
• Human germline genome editing

  2019cites this paper
• Computationally Designed Recombinant-DNA-Based Compounds Production Driven in Plants During Secondary Metabolism and Their Implication in Antimalarial Therapies

  2019cites this paper
• Breaking the germline barrier in a moral vacuum

  2019influential citation
• A fragment-like approach to PYCR1 inhibition.

  2019cites this paper
• Efficient Generation of Pathogenic A-to-G Mutations in Human Tripronuclear Embryos via ABE-Mediated Base Editing

  2019cites this paper
• Mosaicism in CRISPR/Cas9-mediated genome editing.

  2019cites this paper
• Canada's Assisted Human Reproduction Act: Pragmatic Reforms in Support of Research

  2019cites this paper
• Safe CRISPR: Challenges and Possible Solutions.

  2019cites this paper
• The First Chinese Edited Babies: A Leap of Faith in Science

  2019cites this paper
• Genetically Modified Babies and a First Application of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR-Cas9).

  2019cites this paper
• Germ-Inating Solutions or Gene-Rating Problems: An Islamic Perspective on Human Germline Gene Editing

  2019cites this paper
• Germline genome editing versus preimplantation genetic diagnosis: Is there a case in favour of germline interventions?

  2019cites this paper
• Prozess oder Resultat? Der Begriff der genetischen Veränderung in der Debatte um humane Keimbahninterventionen

  2019cites this paper
• Is CRISPR a Security Threat?

  2019cites this paper